|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18,942.05 INR | +2.82% |
|
-2.94% | +24.70% |
| Market Cap | 243B 2.52B 2.21B 2.04B 1.88B 3.54B 3.6B 24.41B 9.57B 119B 9.46B 9.26B 410B | P/E 2027 * |
58x | P/E 2028 * | 42x |
|---|---|---|---|---|---|
| Enterprise Value | 246B 2.55B 2.24B 2.07B 1.9B 3.59B 3.64B 24.71B 9.69B 120B 9.58B 9.37B 415B | EV / Sales 2027 * |
10.7x | EV / Sales 2028 * | 8.81x |
| Free-Float |
62.24% | Yield 2027 * |
0.07% | Yield 2028 * | 0.1% |
Last Transcript: Neuland Laboratories Limited
| 1 day | +2.82% | ||
| 1 week | -2.94% | ||
| Current month | +1.67% | ||
| 1 month | +9.18% | ||
| 3 months | +23.79% | ||
| 6 months | +36.28% | ||
| Current year | +24.70% |
| 1 week | 18,041.55 | 19,355.2 | |
| 1 month | 17,032.7 | 20,072 | |
| Current year | 11,500 | 20,072 | |
| 1 year | 11,500 | 20,072 | |
| 3 years | 3,100.05 | 20,072 | |
| 5 years | 965.85 | 20,072 | |
| 10 years | 247.3 | 20,072 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 46 | 31/03/2026 | |
Abhijit Majumdar
DFI | Director of Finance/CFO | - | 22/11/2022 |
Ajitabh Singh
CTO | Chief Tech/Sci/R&D Officer | - | 28/02/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 31/07/2025 | |
| Director/Board Member | 80 | 30/10/2022 | |
| Director/Board Member | 82 | 11/02/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.82% | -2.94% | +32.98% | +504.69% | 2.45B | ||
| -2.34% | -1.59% | +52.60% | +150.76% | 1,051B | ||
| -1.39% | -3.05% | +52.04% | +48.41% | 609B | ||
| -0.68% | +2.11% | +36.99% | +78.09% | 450B | ||
| -0.75% | +0.30% | +29.77% | +21.15% | 330B | ||
| -1.52% | -1.19% | +34.46% | +35.35% | 284B | ||
| -1.70% | -1.82% | +20.99% | +15.74% | 263B | ||
| -0.58% | +1.11% | -20.18% | -40.59% | 223B | ||
| -0.65% | +1.34% | +23.46% | +56.62% | 198B | ||
| -0.72% | +1.69% | +23.40% | +67.14% | 167B | ||
| Average | -0.60% | -0.07% | +28.65% | +93.74% | 357.75B | |
| Weighted average by Cap. | -1.15% | +0.02% | +37.14% | +72.35% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 23.09B 239M 210M 194M 178M 337M 342M 2.32B 909M 11.3B 899M 879M 38.92B | 27.8B 288M 253M 234M 215M 405M 412M 2.79B 1.09B 13.6B 1.08B 1.06B 46.86B |
| Net income | 4.21B 43.65M 38.26M 35.37M 32.53M 61.37M 62.36M 423M 166M 2.06B 164M 160M 7.1B | 5.81B 60.21M 52.77M 48.78M 44.86M 84.65M 86M 583M 229M 2.84B 226M 221M 9.79B |
| Net Debt | 2.94B 30.46M 26.7M 24.68M 22.7M 42.83M 43.51M 295M 116M 1.44B 114M 112M 4.95B | 1.92B 19.91M 17.45M 16.13M 14.84M 28M 28.45M 193M 75.62M 940M 74.78M 73.14M 3.24B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/07/26 | ₹18,942.05 | +2.82% | 10,883 |
| 17/07/26 | ₹18,422.80 | -1.87% | 1,641 |
| 16/07/26 | ₹18,773.60 | -1.66% | 943 |
| 15/07/26 | ₹19,089.60 | +0.48% | 625 |
| 14/07/26 | ₹18,997.85 | -0.01% | 514 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NEULANDLAB Stock
Select your edition
All financial news and data tailored to specific country editions

















